Vertical Transmission of Microbiomes into Embryo Culture Media and its Association with Assisted Reproductive Outcomes
Publication in refereed journal
CUHK Authors
Full Text
View Full-text in CUHK Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website  |
Altmetrics Information
.
Other information
Abstract"Research Question: Can microbes vertically transmit from semen and follicular fluids to embryo culture media during assisted reproductive technology (ART) treatments?
Design: Spent embryo culture media (SECM) were collected along with seminal fluid and follicular fluid samples from 61 infertility couples undergoing ART treatment at the Prince of Wales Hospital, Hong Kong SAR, China. Metagenomic analysis was conducted to identify the source of microbes in SECM, the correlation between semen microbiomes and male infertility, and the correlation between follicular fluid microbiome and female infertility.
Results: Microbial vertical transmission into SECM was reported in 82.5% of the cases, and semen was the main source of contamination in c-IVF cases. The increased abundances of Staphylococcus and Streptococcus anginosus in semen showed statistically negative impacts on sperm count and total motility, respectively (p <0.001). We observed significant increases in the abundances of Prophyromonas, Neisseria, and Facklamia in follicular fluid in women with anovulation, uterine factor infertility, and unexplained infertility, respectively (p <0.01). Finally, there was no significant correlation between the bacteria identified in all sample types with ART outcomes including fertilization rates, embryo development, the number of available embryos, and clinical pregnancy rates.
Conclusion: Embryo culture media can be contaminated during ART treatment, not only by seminal microbes but also by follicular fluid and other sources of microbes. There were strong correlations between specific microbial taxa in semen and sperm quality as well as between follicular fluid microbiomes and the etiology of female infertility. However, the microbiome of SECM, semen, and follicular fluid showed no significant association with ART treatment outcomes."
Design: Spent embryo culture media (SECM) were collected along with seminal fluid and follicular fluid samples from 61 infertility couples undergoing ART treatment at the Prince of Wales Hospital, Hong Kong SAR, China. Metagenomic analysis was conducted to identify the source of microbes in SECM, the correlation between semen microbiomes and male infertility, and the correlation between follicular fluid microbiome and female infertility.
Results: Microbial vertical transmission into SECM was reported in 82.5% of the cases, and semen was the main source of contamination in c-IVF cases. The increased abundances of Staphylococcus and Streptococcus anginosus in semen showed statistically negative impacts on sperm count and total motility, respectively (p <0.001). We observed significant increases in the abundances of Prophyromonas, Neisseria, and Facklamia in follicular fluid in women with anovulation, uterine factor infertility, and unexplained infertility, respectively (p <0.01). Finally, there was no significant correlation between the bacteria identified in all sample types with ART outcomes including fertilization rates, embryo development, the number of available embryos, and clinical pregnancy rates.
Conclusion: Embryo culture media can be contaminated during ART treatment, not only by seminal microbes but also by follicular fluid and other sources of microbes. There were strong correlations between specific microbial taxa in semen and sperm quality as well as between follicular fluid microbiomes and the etiology of female infertility. However, the microbiome of SECM, semen, and follicular fluid showed no significant association with ART treatment outcomes."
Acceptance Date19/03/2024
All Author(s) ListAlqawasmeh Odai AM, Jiang Xiao-Tao, Cong Luping, Wu Waner, Leung Maran BW, Chung Jacqueline PW, Yim Howard Chi Ho, Fok Ellis KL, Chan David YL
Journal nameReproductive BioMedicine Online
Year2024
Month8
Volume Number49
Issue Number2
PublisherElsevier
Article number103977
ISSN1472-6483
eISSN1472-6491
LanguagesEnglish-United Kingdom
